Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes

Exclusion Criteria

• •Have taken any oral antihyperglycemic medications (OAMs) within 3 months prior to Visit 1.
• •Have had more than one episode of severe hypoglycemia, as defined in the Abbreviations and Definitions section of the protocol, within 6 months prior to entry into the study
• •Are pregnant or intend to become pregnant during the course of the study or are sexually active women of childbearing potential not actively practicing birth control by a method determined by the investigator to be medically acceptable or women who are breastfeeding
• •Are receiving chronic (lasting longer than 14 consecutive days) systemic glucocorticoid therapy (excluding topical, intra-articular, intraocular, and inhaled preparations) or have received such therapy within the 4 weeks immediately preceding Visit 1.
• •Have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication at the time of study entry.